Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,236 | 6,708 | 217 | 890 | 1,833 |
| Receivables | 13 | N/A | N/A | N/A | 0 |
| Other current assets | 0 | 0 | 338 | 0 | 0 |
| TOTAL | $8,447 | $6,845 | $575 | $1,005 | $1,956 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $8,447 | $6,845 | $575 | $1,005 | $1,956 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,882 | 970 | 614 | 407 | 797 |
| Other current liabilities | 5,722 | 2,609 | N/A | N/A | N/A |
| TOTAL | $10,604 | $3,579 | $614 | $407 | $797 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 66 | 0 | 0 | 0 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $10,604 | $3,579 | $614 | $407 | $797 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105 | 79 | 63 | 20 | 20 |
| Common Shares | 1 | N/A | N/A | 2 | 2 |
| Retained earnings | -88,087 | -80,551 | -81,126 | -80,464 | -79,860 |
| Other shareholders' equity | -705 | -639 | 0 | 0 | 0 |
| TOTAL | $-2,157 | $3,266 | $-39 | $598 | $1,159 |
| Total Liabilities And Equity | $8,447 | $6,845 | $575 | $1,005 | $1,956 |